Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 601.78M | 613.23M | 627.78M | 708.97M | 697.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 601.78M | 613.23M | 627.78M | 708.97M | 697.26M |
| Cost of Revenue | 340.47M | 349.83M | 349.75M | 385.71M | 375.07M |
| Gross Profit | 261.31M | 263.41M | 278.03M | 323.26M | 322.20M |
| SG&A Expenses | 249.46M | 243.56M | 255.23M | 273.20M | 265.84M |
| Depreciation & Amortization | 4.98M | 29.23M | 29.23M | 29.23M | 29.23M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 594.91M | 622.62M | 634.21M | 688.13M | 670.13M |
| Operating Income | 6.87M | -9.38M | -6.43M | 20.83M | 27.13M |
| Income Before Tax | -36.82M | -87.63M | -16.25M | -7.97M | -3.64M |
| Income Tax Expenses | -18.86M | 1.44M | -9.78M | 1.47M | 1.97M |
| Earnings from Continuing Operations | -17.96M | -89.07M | -6.47M | -9.44M | -5.61M |
| Earnings from Discontinued Operations | -1.74M | -- | -- | -46.88M | -144.67M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.70M | -89.07M | -6.47M | -56.33M | -150.28M |
| EBIT | 6.87M | -9.38M | -6.43M | 20.83M | 27.13M |
| EBITDA | 45.79M | 56.32M | 55.32M | 50.71M | 91.23M |
| EPS Basic | -0.26 | -1.16 | -0.08 | -0.73 | -1.94 |
| Normalized Basic EPS | -0.25 | -0.36 | -0.33 | -0.05 | -0.02 |
| EPS Diluted | -0.26 | -1.16 | -0.08 | -0.74 | -1.94 |
| Normalized Diluted EPS | -0.25 | -0.36 | -0.33 | -0.05 | -0.02 |
| Average Basic Shares Outstanding | 76.91M | 76.70M | 76.43M | 76.70M | 77.29M |
| Average Diluted Shares Outstanding | 76.91M | 76.70M | 76.43M | 76.70M | 77.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |